Becure Pharma

Eltrombopag is an oral thrombopoietin receptor agonist used to treat thrombocytopenia (low platelet count) in various clinical conditions. It works by stimulating the thrombopoietin receptor (TPO-R), leading to the increased production of platelets in the bone marrow. It is mainly used in patients with chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and chronic hepatitis C who require additional support to increase platelet counts.

Eltrombopag 50 mg tablets are used as part of the treatment for these conditions to help reduce the risk of bleeding associated with low platelet counts.

Paclitaxel is a chemotherapy medication used to treat a variety of cancers, including breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and Kaposi's sarcoma. It is a taxane-class drug that works by interfering with the microtubules in cancer cells, which are critical for cell division. By disrupting the microtubule structure, paclitaxel prevents cancer cells from dividing and spreading, ultimately leading to cell death.

Paclitaxel Injection I.P. 100 mg is administered intravenously (IV) and is often used as part of combination chemotherapy regimens to treat different types of cancer. The dosage and treatment schedule depend on the type of cancer being treated, the patient's overall health, and how the body responds to the medication.

Olaparib is an oral medication used primarily in the treatment of certain types of cancer, specifically cancers with mutations in the BRCA (BReast CAncer gene) genes, which are associated with hereditary breast and ovarian cancers. It belongs to a class of drugs known as PARP inhibitors. PARP (Poly ADP Ribose Polymerase) is an enzyme that helps repair damaged DNA in cells. By inhibiting PARP, Olaparib prevents cancer cells from repairing their DNA, causing them to accumulate damage and ultimately leading to their death, while healthy cells can usually repair their DNA more effectively.

Olaparib Tablets 150 mg are typically used to treat ovarian cancer, breast cancer, and certain other cancers, particularly in patients who have mutations in the BRCA1 or BRCA2 genes, which impair their ability to repair DNA damage.

Pazopanib is an oral tyrosine kinase inhibitor (TKI) used in the treatment of certain cancers. It works by inhibiting the activity of multiple receptors involved in the growth of cancer cells, including those related to vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and c-Kit, which are involved in tumor growth, angiogenesis (formation of new blood vessels), and metastasis.

Pazopanib is primarily used to treat renal cell carcinoma (RCC), a type of kidney cancer, and soft tissue sarcoma (STS), a group of cancers that arise from soft tissues such as muscles, fat, and connective tissues. It may also be used in combination with other therapies or as a second-line treatment in cases where other options have failed.

Mounjaro 5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the medication properly in the refrigerator.

Abritiga 250mg Tablet should not be taken on an empty stomach. Taking it with food may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Abritiga 500mg Tablet should be taken on an empty stomach, either one hour before or at least two hours after a meal. Taking it with food may increase the blood levels of Abritiga 500mg Tablet, which may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to.

Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, which is used to treat various blood cancers and also a serious complication of allogeneic stem cell transplants called chronic graft versus host disease (cGVHD).

Ibrutinib helps to slow down how quickly certain blood cancers progress by working against cancerous B cells, a type of white blood cell. It does this by blocking Bruton's tyrosine kinase (BTK) signaling. BTK is a protein found on B cells that instructs B cells to remain alive and multiply. Ibrutinib also blocks the activity of a similar protein called interleukin-2-inducible T-cell kinase (ITK). It's thought that this action and it's ability to block BTK helps in cGVHD

Piclib 100mg Capsule is used to treat patients with certain types of breast cancer (estrogen receptor-positive, human epidermal growth factor receptor 2-negative) which have spread to other organs. It is given together with hormonal anticancer therapies.

Manufactured byM biotechMedicine brandAbiratonMedicine formTabletMedicine name abiraterone acetate tablets ipMedicine strength250 mgPackaging size120 tabletsSalt compositionAbiraterone acetate